Advertisement
expert Q&A
expert Q&A
12/31/2023

Emile d’Angremont, MSc

Emile d’Angremont, MSc
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
12/31/2023
Expert Q&A
Expert Q&A
05/03/2022
New research investigated the nervous system cell types in which putative migraine-associated genes are expressed. Lead author William Renthal, MD, PhD, answers our questions about this research.
05/03/2022
Seizure
Seizure
04/17/2020
A new study suggests that late-onset unprovoked seizures of unknown etiology may be associated with a doubled risk of developing dementia among older veterans. Neurology Consultant spoke with corresponding...
04/17/2020
Treatment
Treatment
03/12/2020
New findings suggest that tau-positron emission tomography signal can predict future brain atrophy in individuals in the early symptomatic stages of Alzheimer disease. The study’s lead author, Renaud La...
03/12/2020
genetics
genetics
01/27/2020
Mingyu Liang, MB, PhD, answers our questions about his research into the dark genome’s function in hypertension.
01/27/2020
Speech
Speech
08/23/2019
A study being presented at the ANA 2019 annual meeting highlights the connection between primary progressive aphasia and Alzheimer disease. Speaker and lead researcher Marek-Marsel Mesulam, MD, answers our...
08/23/2019
Dementia
Dementia
02/17/2017
Michael Gordon, MD, shares clinical advice for engaging with patients who have cognitive concerns ranging from subjective cognitive impairment to dementia.
02/17/2017
Genetics
Genetics
09/18/2015
Alison Goate, DPhil, answered our questions about her research on the role of genetics in Alzheimer disease onset, a topic she will also be presenting at 144th Annual Meeting of the American Neurological...
09/18/2015